Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-23-001267
Filing Date
2023-03-31
Accepted
2023-03-31 15:36:04
Documents
63
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2329471.htm   iXBRL 10-K 1158974
2 EXHIBIT 4.2 exhibit_4-2.htm EX-4.2 13008
3 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9282
4 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 9475
5 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5272
6 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5435
12 GRAPHIC image1.jpg GRAPHIC 3875
13 GRAPHIC image2.jpg GRAPHIC 33539
14 GRAPHIC image00005.jpg GRAPHIC 103294
15 GRAPHIC image00007.jpg GRAPHIC 11182
  Complete submission text file 0001178913-23-001267.txt   5005962

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atms-20221231.xsd EX-101.SCH 41413
8 XBRL CALCULATION FILE atms-20221231_cal.xml EX-101.CAL 34298
9 XBRL DEFINITION FILE atms-20221231_def.xml EX-101.DEF 103645
10 XBRL LABEL FILE atms-20221231_lab.xml EX-101.LAB 512691
11 XBRL PRESENTATION FILE atms-20221231_pre.xml EX-101.PRE 202902
57 EXTRACTED XBRL INSTANCE DOCUMENT zk2329471_htm.xml XML 568017
Mailing Address 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507
Business Address 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24431 | Film No.: 23787129
SIC: 2890 Miscellaneous Chemical Products